VivaChek™ Biotech (Hangzhou) Co., Ltd., a leading global provider of medical diagnostic solutions, is pleased to announce that its VivaDiag™ hCG Pregnancy Rapid Test has received official medical device registration approval in Brazil. This milestone highlights the company's commitment to expanding its presence in the international market, particularly in Latin America.

The VivaDiag™ hCG Pregnancy Rapid Test is a fast and accurate tool designed to detect the presence of human chorionic gonadotropin (hCG) in urine, commonly used for early pregnancy detection. The product has been registered under the Brazilian Health Regulatory Agency (ANVISA) with the registration number 82195300007 and classified as a Class II medical device.

This approval strengthens VivaChek’s position in the global diagnostics market and opens up new opportunities in Brazil and neighboring countries. The VivaDiag™ hCG Pregnancy Rapid Test is expected to meet growing demand for reliable, easy-to-use diagnostic tools, particularly among healthcare professionals and home users.